IOVS Blood
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamagami, S.
Right arrow Articles by Dana, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamagami, S.
Right arrow Articles by Dana, M. R.
(Investigative Ophthalmology and Visual Science. 1999;40:2892-2897.)
© 1999 by The Association for Research in Vision and Ophthalmology, Inc.

Differential Chemokine Gene Expression in Corneal Transplant Rejection

Satoru Yamagami, Dai Miyazaki, Santa J. Ono and M. Reza Dana

From the Laboratory of Immunology, Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts.

PURPOSE. To evaluate the differential gene expression of chemokines after corneal transplantation and to determine the chemokines associated with allograft rejection.

METHODS. Orthotopic mouse corneal transplantation was performed in two fully mismatched-strain combinations using C57BL/6 (H-2b) and BALB/c (H-2d) mice as recipients and BALB/c and C57BL/6 mice as donors. Normal nonsurgical eyes served as negative control specimens and syngeneic transplants (isografts) as control specimens for the alloimmune response. Chemokine gene expression in accepted and rejected allografts and appropriate control specimens was determined by a multiprobe RNase protection assay system.

RESULTS. In eyes with rejected allografts, there was overexpression of regulated on activation normal T-cell expressed and secreted (RANTES), macrophage inflammatory protein (MIP)-1{alpha}, MIP-1ß, MIP-2, and monocyte chemotactic protein (MCP)-1 in both C57BL/6 and BALB/c recipients. In addition, C57BL/6 eyes with rejected allografts expressed very high levels of interferon-{gamma}–inducible protein of 10 kDa (IP-10) mRNA, in contrast to BALB/c eyes with rejected allografts, in which IP-10 expression remained very low. In contrast, lymphotactin gene expression increased only slightly in rejected allografts, and eotaxin mRNA, which was also detected in normal eyes, remained unchanged among isograft and allograft groups. T-cell activation gene (TCA)-3 mRNA was not detected in any of the assayed eyes.

CONCLUSIONS. Increased expression of mRNA for select chemokines of the CXC ({alpha}) and CC (ß) families is associated with corneal allograft rejection. Significantly elevated IP-10 gene expression in high-rejector C57BL/6, but not in low-rejector BALB/c, hosts suggests that differential activation of chemokines may be related to differences in alloimmune reactivity observed among different murine strains.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
S. Nakao, Y. Hata, M. Miura, K. Noda, Y. N. Kimura, S. Kawahara, T. Kita, T. Hisatomi, T. Nakazawa, Y. Jin, et al.
Dexamethasone Inhibits Interleukin-1{beta}-Induced Corneal Neovascularization: Role of Nuclear Factor-{kappa}B-Activated Stromal Cells in Inflammatory Angiogenesis
Am. J. Pathol., September 1, 2007; 171(3): 1058 - 1065.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. Hamrah, S. Yamagami, Y. Liu, Q. Zhang, S. S. Vora, B. Lu, C. J. Gerard, and M. R. Dana
Deletion of the Chemokine Receptor CCR1 Prolongs Corneal Allograft Survival
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1228 - 1236.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Ebihara, S. Yamagami, S. Yokoo, S. Amano, and A. Murakami
Involvement of C-C Chemokine Ligand 2-CCR2 Interaction in Monocyte-Lineage Cell Recruitment of Normal Human Corneal Stroma
J. Immunol., March 1, 2007; 178(5): 3288 - 3292.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. A. McInnis, A. Britain, R. N. Lausch, and J. E. Oakes
Synthesis of {alpha}-Chemokines IP-10, I-TAC, and MIG Are Differentially Regulated in Human Corneal Keratocytes
Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1668 - 1674.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Yamagami, P. Hamrah, K. Miyamoto, D. Miyazaki, I. Dekaris, T. Dawson, B. Lu, C. Gerard, and M. R. Dana
CCR5 Chemokine Receptor Mediates Recruitment of MHC Class II-Positive Langerhans Cells in the Mouse Corneal Epithelium
Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1201 - 1207.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K.-Y. Chau, A. M. Keane-Myers, M. Fedele, Y. Ikeda, R. J. Creusot, L. Menozzi, D. J. Cousins, G. Manfioletti, L. Feigenbaum, A. Fusco, et al.
IFN-{gamma} gene expression is controlled by the architectural transcription factor HMGA1
Int. Immunol., March 1, 2005; 17(3): 297 - 306.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. H. Ritchie, R. A. Fillmore, R. N. Lausch, and J. E. Oakes
A Role for NF-{kappa}B Binding Motifs in the Differential Induction of Chemokine Gene Expression in Human Corneal Epithelial Cells
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2299 - 2305.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. R. Dana
Corneal Antigen-Presenting Cells: Diversity, Plasticity, and Disguise The Cogan Lecture
Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 722 - 727.
[Full Text] [PDF]


Home page
Arch OphthalmolHome page
P. Hamrah, Y. Liu, Q. Zhang, and M. R. Dana
Alterations in Corneal Stromal Dendritic Cell Phenotype and Distribution in Inflammation
Arch Ophthalmol, August 1, 2003; 121(8): 1132 - 1140.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. Hamrah, Q. Zhang, Y. Liu, and M. R. Dana
Novel Characterization of MHC Class II-Negative Population of Resident Corneal Langerhans Cell-Type Dendritic Cells
Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 639 - 646.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Yamagami and M. R. Dana
The Critical Role of Lymph Nodes in Corneal Alloimmunization and Graft Rejection
Invest. Ophthalmol. Vis. Sci., May 1, 2001; 42(6): 1293 - 1298.
[Abstract] [Full Text]


Home page
Arch OphthalmolHome page
Y. Qian, I. Dekaris, S. Yamagami, and M. R. Dana
Topical Soluble Tumor Necrosis Factor Receptor Type I Suppresses Ocular Chemokine Gene Expression and Rejection of Allogeneic Corneal Transplants
Arch Ophthalmol, December 1, 2000; 118(12): 1666 - 1671.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Association for Research in Vision and Ophthalmology